Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE: 300573)

Shenyang Xingqi Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	503.31	480.42	515.45	686.36	37.22	49.96
Cash & Short-Term Investments	503.31	480.42	515.45	686.36	37.22	49.96
Cash Growth	18.33%	-6.80%	-24.90%	1744.12%	-25.51%	76.10%
Accounts Receivable	263.01	252.1	194.96	170.62	158.23	130.39
Other Receivables	3.95	3.93	4.62	5.84	3.15	1.91
Receivables	266.96	256.03	199.58	176.46	161.37	132.3
Inventory	145.09	136.03	122.27	92.33	68.31	79.87
Other Current Assets	32.31	32.71	27.87	29.27	27.32	19.64
Total Current Assets	947.66	905.19	865.17	984.42	294.22	281.78
Property, Plant & Equipment	888.23	837.35	695.92	548.6	527.9	474.25
Long-Term Investments	10	-	-	-	-	2.2
Other Intangible Assets	136.72	78.29	27.66	22.83	23.83	23.84
Long-Term Deferred Tax Assets	48.83	38.57	23.77	30.45	33.87	13.28
Long-Term Deferred Charges	69.77	118.76	105.03	60.77	28.22	9.02
Other Long-Term Assets	84.56	45.68	65.39	39.78	57.67	48
Total Assets	2,186	2,024	1,783	1,687	965.7	852.37
Accounts Payable	18.19	17.57	19.46	13.31	6.67	26.52
Accrued Expenses	75.44	125.36	103.97	108.91	91.74	67.13
Short-Term Debt	230.18	70.06	-	100	80	90
Current Portion of Leases	9.42	6.87	7.12	4.18	-	-
Current Income Taxes Payable	59.82	5.74	-	11.69	-	8.77
Current Unearned Revenue	2.36	6.55	2.01	6.11	5.11	-
Other Current Liabilities	87.85	27.98	19.89	22.63	28.98	28.65
Total Current Liabilities	483.25	260.12	152.45	266.83	212.49	221.07
Long-Term Leases	7.69	2.22	6.69	7.1	-	-
Long-Term Unearned Revenue	67.07	71.58	71.5	68.42	59.15	56.4
Total Liabilities	558.01	333.92	230.63	342.35	271.64	277.46
Common Stock	174.42	124.59	88.56	88.1	82.37	82.43
Additional Paid-In Capital	862.02	891.01	852.36	782.68	288.16	256.23
Retained Earnings	591.32	674.32	611.4	479	327.11	249.41
Treasury Stock	-	-	-	-5.28	-13.26	-19.56
Comprehensive Income & Other	-	-	-	-	-2.2	-
Total Common Equity	1,628	1,690	1,552	1,344	682.19	568.51
Minority Interest	-	-	-	-	11.87	6.39
Shareholders' Equity	1,628	1,690	1,552	1,344	694.06	574.9
Total Liabilities & Equity	2,186	2,024	1,783	1,687	965.7	852.37
Total Debt	247.29	79.15	13.81	111.28	80	90
Net Cash (Debt)	256.02	401.27	501.64	575.08	-42.78	-40.04
Net Cash Growth	-29.58%	-20.01%	-12.77%	-	-	-
Net Cash Per Share	1.47	2.30	2.91	3.59	-0.27	-0.26
Filing Date Shares Outstanding	174.42	174.42	173.57	172.67	161.44	145.76
Total Common Shares Outstanding	174.42	174.42	173.57	172.67	161.44	145.76
Working Capital	464.41	645.07	712.72	717.59	81.72	60.71
Book Value Per Share	9.33	9.69	8.94	7.79	4.23	3.90
Tangible Book Value	1,491	1,612	1,525	1,322	658.36	544.67
Tangible Book Value Per Share	8.55	9.24	8.78	7.65	4.08	3.74
Buildings	-	476.93	470.69	350.19	347.48	343.48
Machinery	-	711.75	534.35	481.36	438.86	318.61
Construction In Progress	-	106.16	70.12	34.94	22.31	51.88

Source: S&P Capital IQ. Standard template. Financial Sources.